Purple Biotech (PPBT) Prepaid Assets (2016 - 2026)
Purple Biotech (PPBT) posted quarterly Prepaid Assets of $353000.0 for Q1 2026, down 17.52% year-over-year from $428000.0 in Q1 2025, and up 20.89% quarter-over-quarter from $292000.0 in Q4 2025.
Purple Biotech (PPBT) Prepaid Assets (2016 - 2026) Analysis & Trends
Purple Biotech (PPBT) has reported Prepaid Assets for 11 consecutive years, with $353000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 17.52% year-over-year to $353000.0; the TTM figure through Mar 2026 stood at $353000.0 (down 17.52% YoY), while the FY2025 annual figure was $292000.0, down 23.96% from the prior year.
- Prepaid Assets climbed to $353000.0 in Q1 2026 per PPBT's latest filing, from $292000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $2.4 million in Q1 2022 and bottomed at $292000.0 in Q4 2025.
- Historically, Prepaid Assets has averaged $780235.3 across 5 years, with a median of $548000.0 in 2024.
- Annual changes were most pronounced in 2022 — Prepaid Assets soared 57.96% — and 2023, when it tumbled 67.1%.
- Purple Biotech's Prepaid Assets stood at $1.1 million in 2022, then sank by 67.1% to $376000.0 in 2023, then climbed by 2.13% to $384000.0 in 2024, then fell by 23.96% to $292000.0 in 2025, then gained by 20.89% to $353000.0 in 2026.
- Business Quant data shows PPBT's Prepaid Assets at $353000.0 in Q1 2026, $292000.0 in Q4 2025, and $320000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Purple Biotech | 133.62 | 133.62 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 353,000.00 |
| Dec 31, 2025 | 292,000.00 |
| Sep 30, 2025 | 320,000.00 |
| Jun 30, 2025 | 394,000.00 |
| Mar 31, 2025 | 428,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Sep 30, 2024 | 638,000.00 |
| Jun 30, 2024 | 473,000.00 |
| Mar 31, 2024 | 548,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Sep 30, 2023 | 634,000.00 |
| Jun 30, 2023 | 984,000.00 |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 1.43 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | 1.27 Mn |
| Sep 30, 2021 | 1.13 Mn |
| Jun 30, 2021 | 1.12 Mn |